Research In Practice Blog

2025 Year in Review
2025 YEAR IN REVIEW
Share  

As 2025 comes to a close, we are reflecting on a year that has been both challenging and rewarding for the Center. This extraordinary year presents an opportunity to highlight and share some of our achievements, showcasing the successes and important work of our faculty, other investigators, and research staff over the past year. 

About Clinical Futures:  

  • As a Children’s Hospital of Philadelphia (CHOP) Research Institute Center of Emphasis, we celebrate 18 years of innovative pediatric clinical effectiveness research and collaboration. (Three of those years being ‘Clinical Futures.’)  
     
  • We’ve expanded our Research In Practice Blog and have posted over 100 entries.  
     
  • With 110 faculty members, over 120 researchers and staff members, we are one of the largest Centers of Emphasis within the CHOP Research Institute.  
     
  • In 2025, we hired 8 clinical research staff members, and we added 7 new faculty members to the Center. Those new faculty members include Drs. Grace Chan, Sanjiv Mehta, Anna Costello, Elizabeth Diemer, Nikhil Pai, Michael Luke, and Pranita Tamma. They are a wonderfully talented group, and I am so pleased that they joined us.
     
  • We hosted 28 seminars led by core faculty, fellows, or collaborators.  
     
  • These included 8 speaker series sessions and 20 works-in-progress sessions, which allowed presenters to receive feedback from fellows and faculty at all levels for projects in all stages of development.  
     
  • We also hosted 2 visiting speakers who presented topics aligned with our methodological pillars and overall mission.  
     
  • In addition, we co-hosted 5 speaker series with the Clinical Trials Research Affinity Group.
     
  • 5 fellows are currently participating in the Pediatric Hospital Epidemiology and Outcomes Research Training (PHEOT) Fellowship co-directed by Clinical Futures faculty.  
     
  • 2 fellows are currently participating in the AGP Fellowship co-directed by Clinical Futures Core Faculty Member Kate Yun, MD, MHS.
     
  • 5 fellows are currently participating in the Clinical Pharm T32 fellowship co-directed by Clinical Futures Core Faculty Member Kevin Downes, MD.

Awards and Funding:  

  • Our Pilot Grants Program:
    • In February 2025, we announced our pilot grant recipients:
      • Charmaine Mutucumarana, MD, Dr. Rebecca Same, MD, and Kathleen Chiotos, MD, MSCE 
        Formative Evaluation of Clinician Knowledge, Attitudes, and Practices on Utilization of Procalcitonin (PCT) in a Pediatric Health System

        Clinical Futures / PolicyLab Pilot Grant program, Clinical Effectiveness Track

    • This month, we announced our most recent round of pilot grant recipients, including:
       
      • Michael Luke, MD, MSPH; Chén Kenyon, MD, MSHP; Jordan Wood, MPH  
        Prevalence and Predictors of Guideline-Discordant Albuterol Co-Prescribing among Hospitalized Children with Asthma on SMART   
        Clinical Futures Implementation Science Track  
      • Brooke Luo, MD; Halley Ruppel, PhD, RN; James Won, PhD; Eric Shelo, MD; Kenrick Cato, PhD, RN  
        Clinician-Led Evaluation and Assessment of Responsible AI (CLEAR-AI): Developing an evaluation framework for the use of generative AI in pediatrics  
        Clinical Futures / PolicyLab Pilot Grant program, Clinical Effectiveness Track  
      • Tracy Waasdorp, PhD; Brooke Paskewich, PsyD  
        Advancing Early Childhood Socioemotional Skills and Aggression Prevention: Partnering to Refine the Novel Friendship Explorers Program  
        Clinical Futures / PolicyLab Pilot Grant program, Clinical Effectiveness Track
         
    • You can learn more about our pilot grant programs and previous awardees by visiting the pilot grant pages on PolicyLab’s website and by visiting the pilot grant program section of Clinical Futures' website.
       
  • Clinical Futures faculty members were awarded over $66M in new grant funding in the past year.  
     
  • This brings total grant funding obtained by Clinical Futures faculty members since inception to approximately $439M. We share this figure to show our gratitude and appreciation to our funding partners and highlight what these awards allow us to do as a Center. These funds support the vital work and research of our faculty, principal investigators, and staff as we continue to discover best practices and improve the standard of care delivered to our patients.  
     
  • Our grant funding effort was greatly aided by the Clinical Futures/PolicyLab Grant Writing unit, which was involved in the submission of a truly remarkable 74 grant proposals in the past calendar year.  
     
  • CHOP Research Institute awarded five CHOP researchers with Clinical Fellow/Instructor K-Readiness Pilot Grants. Recipients from Clinical Futures include:
    • Hilary Whitworth, MD, MSCE received funding for her pilot project titled 'Predicting Recurrent Central Venous Catheter Associated Venous Thromboembolism' which aims to develop risk-adapted thromboprophylaxis strategies to decrease recurrent thrombosis in children.
    • Daniel Zheng, MD, MHS, MSHP was awarded for the pilot project ‘Characterizing Financial Toxicity and Caregiver Work Disruption During Pediatric AML Treatment.’ This prospective, mixed methods study aims to utilize surveys and interviews to better understand the longitudinal experience of how treatment for pediatric AML, a rare blood cancer, affects caregivers' experience with work and finances. Dr. Zheng's mentors include Clinical Futures' Core Faculty Member Richard Aplenc, MD, PhD, MSCE, and Clinical Futures Affiliate Faculty Member Kelly Getz, PhD, MPH. You can learn more about these grants and other recipients on the Research Institute’s Cornerstone Blog here.

Publications and Press:  

Now that you have learned more about Clinical Futures, we encourage you to stay engaged with us. Subscribe to the Research in Practice blog and follow us on our LinkedIn, X, and YouTube, for the latest news and research from the Center. We look forward to what 2026 will bring as we continue to advance clinical effectiveness research and improve outcomes for our patients and their families.